MacroGenics, Inc. (MGNX)
NASDAQ: MGNX · Real-Time Price · USD
1.545
+0.055 (3.69%)
Jul 16, 2025, 2:07 PM - Market open
MacroGenics Stock Forecast
Stock Price Forecast
The 9 analysts that cover MacroGenics stock have a consensus rating of "Hold" and an average price target of $5.33, which forecasts a 244.98% increase in the stock price over the next year. The lowest target is $2 and the highest is $14.
Price Target: $5.33 (+244.98%)
Analyst Consensus: Hold
* Price targets were last updated on May 20, 2025.
Analyst Ratings
The average analyst rating for MacroGenics stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 8 | 8 | 8 | 7 | 7 | 7 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 10 | 10 | 9 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B. Riley Securities | B. Riley Securities | Hold Maintains $5 → $3 | Hold | Maintains | $5 → $3 | +94.17% | May 20, 2025 |
| Stifel | Stifel | Hold Maintains $6 → $5 | Hold | Maintains | $6 → $5 | +223.62% | May 14, 2025 |
| Barclays | Barclays | Buy Maintains $8 → $3 | Buy | Maintains | $8 → $3 | +94.17% | May 14, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Maintains $4 → $2 | Hold | Maintains | $4 → $2 | +29.45% | Mar 25, 2025 |
| JMP Securities | JMP Securities | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Nov 7, 2024 |
Financial Forecast
Revenue This Year
37.43M
from 149.96M
Decreased by -75.04%
Revenue Next Year
28.69M
from 37.43M
Decreased by -23.36%
EPS This Year
-2.25
from -1.07
EPS Next Year
-1.76
from -2.25
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 44.0M | 75.1M | 103.3M | ||
| Avg | 37.4M | 28.7M | 52.8M | ||
| Low | 29.4M | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -70.7% | 100.6% | 260.2% | ||
| Avg | -75.0% | -23.4% | 84.2% | ||
| Low | -80.4% | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -1.18 | -0.13 | -0.85 |
| Avg | -2.25 | -1.76 | -2.15 |
| Low | -2.99 | -3.19 | -3.38 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.